These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 50163)

  • 1. Reversible interstitial pneumonitis associated with low dose bleomycin.
    O'Neill TJ; Kardinal CG; Tierney LM
    Chest; 1975 Aug; 68(2):265-7. PubMed ID: 50163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of severe bleomycin-induced pneumonitis.
    Brown WG; Hasan FM; Barbee RA
    JAMA; 1978 May; 239(19):2012-4. PubMed ID: 76689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 67Ga accumulation in pulmonary lesions associated with bleomycin toxicity.
    Richman SD; Levenson SM; Bunn PA; Flinn GS; Johnston GS; DeVita VT
    Cancer; 1975 Dec; 36(6):1966-72. PubMed ID: 54210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bleomycin-induced lung changes in the roentgen picture].
    Umek H; Dupal HD
    Rofo; 1976 Dec; 125(6):532-7. PubMed ID: 64443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin-induced pulmonary toxicity.
    Jules-Elysee K; White DA
    Clin Chest Med; 1990 Mar; 11(1):1-20. PubMed ID: 1691067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial pneumonitis associated with bleomycin therapy.
    Luna MA; Bedrossian CW; Lichtiger B; Salem PA
    Am J Clin Pathol; 1972 Nov; 58(5):501-10. PubMed ID: 4118423
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe bleomycin lung toxicity: reversal with high dose corticosteroids.
    Maher J; Daly PA
    Thorax; 1993 Jan; 48(1):92-4. PubMed ID: 7679525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interstial pneumopathy after low dose bleomycin therapy].
    Frey F; Marone C; Zimmermann A
    Schweiz Med Wochenschr; 1977 Oct; 107(40):1418-22. PubMed ID: 72411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Bleomycin toxicity.
    Adler S; Shimaoka K; Tsukada Y
    JAMA; 1976 Jun; 235(26):2814. PubMed ID: 58999
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results with the cytostatic agent bleomycin in tumour therapy (author's transl)].
    Baumgartner G
    Wien Klin Wochenschr; 1973 Oct; 85(42):686-92. PubMed ID: 4128921
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lung disease due to bleomycin (proceedings)].
    De Maria D; Pantusa M; Falchi AM
    Radiol Med; 1977 Apr; 63(4):360-3. PubMed ID: 73204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative toxic and therapeutic effects of adriamycin and bleomycin in malignant lymphoma (author's transl)].
    De Lena M; Beretta G
    Tumori; 1972; 58(1):17-27. PubMed ID: 4134612
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased levels of tumor necrosis factor-α involved in rituximab-related acute pulmonary fibrosis in diffuse large B-cell lymphoma.
    Zhang X; Guo X; Pan J
    Am J Clin Pathol; 2015 May; 143(5):725-7. PubMed ID: 25873507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of bleomycin lung.
    Brown LD; Reimer RR; Ahmad M; Hewlett JS
    Cleve Clin Q; 1980; 47(2):97-100. PubMed ID: 6156778
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bleomycin-induced pulmonary fibrosis following chemotherapy of ovarian granulosa cell tumor].
    Theile A; Kemper P
    Pneumologie; 1998 Jun; 52(6):325-32. PubMed ID: 9715647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
    Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
    N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset cyclophosphamide-induced interstitial pneumonitis.
    Spector JI; Zimbler H; Ross JS
    JAMA; 1979 Dec; 242(26):2852-4. PubMed ID: 390173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin toxicity simulating metastatic nodules to the lungs.
    McCrea ES; Diaconis JN; Wade JC; Johnston CA
    Cancer; 1981 Sep; 48(5):1096-100. PubMed ID: 6168362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal interstitial pneumonitis induced by low dosage of bleomycin in an esophageal cancer patient.
    Sannohe Y; Hirano M; Shirakusa T; Hiratsuka R; Doki K; Inutsuka S
    Jpn J Surg; 1979 Dec; 9(4):366-71. PubMed ID: 94614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.